Clinical Trials Directory

Trials / Unknown

UnknownNCT06100302

Study on the Mechanism of Immune Inflammation in Cognitive Impairment of Depression

The First Affiliated Hospital of Xi'an Jiaotong University

Status
Unknown
Phase
Study type
Observational
Enrollment
400 (estimated)
Sponsor
First Affiliated Hospital Xi'an Jiaotong University · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers

Summary

The patients with depression were observed and followed up to evaluate the changes of symptoms and cognitive function in patients with depression at different time points before and after drug treatment. At the same time, immunometabolism indicators in serum, urine and stool were detected to screen out immunoinflammatory markers related to cognitive function and treatment response in patients with depression, hoping to provide a new strategy for optimal treatment of depression.

Detailed description

1. Participants were included according to the inclusion and exclusion criteria, and demographic data of depressed patients and healthy controls were recorded, including age, sex, ethnicity, occupation, etc. Subjects in the depression group were treated with antidepressants (as recommended by the guidelines) and were followed up baseline, 2 weeks, 8 weeks, 12 weeks, and 24 weeks after treatment, respectively. At each follow-up point, symptoms were assessed using Hamilton Depression Scale (HAMD), Hamilton Anxiety Scale (HAMA), Depression Screening Scale (PHQ-9) and Generalized Anxiety Scale (GAD-7), and cognitive function was assessed using Thinc-it at three follow-up points: baseline, 12 weeks after treatment, and 24 weeks after treatment. General data were compared between patients with depression and healthy controls at baseline. 2. The depression group was followed up. Serum and fecal of patients with depression were collected at 5 follow-up points at baseline, 2 weeks, 8 weeks, 12weeks and 24 weeks after treatment, and serum metabolic indexes and fecal metagenome were detected.

Conditions

Interventions

TypeNameDescription
OTHERno-interventionno-intervention

Timeline

Start date
2022-07-01
Primary completion
2024-07-01
Completion
2025-02-01
First posted
2023-10-25
Last updated
2023-10-25

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06100302. Inclusion in this directory is not an endorsement.